(Q38126030)

29 August 2017

A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions (English)

1 reference

29 August 2017

1 reference

Rafael Guimarāes dos Santos

series ordinal

1

0 references

publication date

1 April 2013

1 reference

Journal of Psychoactive Drugs

29 August 2017

1 reference

29 August 2017

45

1 reference

29 August 2017

2

1 reference

29 August 2017

179-188

1 reference

Health status of ayahuasca users

29 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Inhibition by β-carbolines of monoamine uptake into a synaptosomal preparation: Structure-activity relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Fast and slow metabolizers of Hoasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Platelet serotonin uptake sites increased in drinkers of ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Serotonin syndrome and drug combinations: focus on MAOI and RIMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Bringing ayahuasca to the clinical research laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Death following ingestion of MDMA (ecstasy) and moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Clinical pharmacology of MAO inhibitors: safety and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Syrian rue tea: a recipe for disaster

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

Serotonin toxicity involving MDMA (ecstasy) and moclobemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02791072.2013.785846

10.1080/02791072.2013.785846

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23909005